| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,6 k € | -98.1% | 136,9 k € | +19.6% | 114,5 k € | -6.3% | 122,2 k € | -6.2% | 130,3 k € | +0.6% | 129,5 k € | -8.7% | 141,8 k € | -5.5% | 150,1 k € | -3.0% | 154,8 k € | -6.7% | 165,9 k € | |
| EBITDA | 2,6 k € | -98.1% | 136,1 k € | +24.8% | 109,1 k € | -3.5% | 113,0 k € | -0.8% | 113,9 k € | +11.2% | 102,5 k € | -7.7% | 111,0 k € | -14.3% | 129,5 k € | +35.4% | 95,7 k € | -33.2% | 143,3 k € | |
| Operating profit | -22,9 k € | -121.0% | 108,7 k € | +48.5% | 73,2 k € | +1.4% | 72,2 k € | +6.2% | 67,9 k € | +20.2% | 56,5 k € | -14.2% | 65,8 k € | -27.5% | 90,9 k € | +75.0% | 51,9 k € | -48.4% | 100,7 k € | |
| Profit/loss | -28,2 k € | -130.7% | 91,8 k € | +55.1% | 59,2 k € | +12.0% | 52,8 k € | +7.9% | 49,0 k € | +54.7% | 31,6 k € | -21.3% | 40,2 k € | -30.5% | 57,9 k € | +147.9% | 23,4 k € | -55.6% | 52,6 k € | |
| Equity | 415,8 k € | -6.4% | 444,0 k € | +26.1% | 352,2 k € | +20.2% | 293,0 k € | +25.2% | 234,0 k € | +26.5% | 185,0 k € | +20.6% | 153,4 k € | +25.5% | 122,2 k € | +38.4% | 88,3 k € | +35.9% | 65,0 k € | |
| Total assets | 554,0 k € | +15.1% | 481,2 k € | -42.0% | 829,6 k € | +13.1% | 733,8 k € | +9.9% | 667,5 k € | +5.8% | 631,1 k € | +6.7% | 591,7 k € | -1.5% | 600,9 k € | +7.4% | 559,5 k € | -1.2% | 566,4 k € | |
| Cash | 277,6 k € | -18.6% | 341,2 k € | -37.3% | 543,9 k € | +30.4% | 417,1 k € | +2.1% | 408,6 k € | +24.4% | 328,5 k € | +27.4% | 257,8 k € | +15.5% | 223,2 k € | +46.7% | 152,1 k € | +88.4% | 80,7 k € | |
| Debts | 138,2 k € | +271.3% | 37,2 k € | -92.1% | 473,3 k € | +8.4% | 436,7 k € | +0.7% | 433,6 k € | -2.8% | 446,1 k € | +1.8% | 438,4 k € | -8.4% | 478,6 k € | +1.6% | 471,1 k € | -6.0% | 501,4 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1,6 | ||||||||||
Private limited company · Seneffe · incorporated on 22/12/2014
Private limited company loss-making in the latest fiscal year. Cash position declining (-18.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MARIEC.C-PHARMA is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette